Molecular Pharmaceutics
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.9 | Q1 | 79.5% | 0.957 | Q1 | 82.8% |
| 2024 | 4.5 | Q1 | 82.2% | 0.968 | Q1 | 83.3% |
| 2023 | 4.5 | Q1 | 83.4% | 0.940 | Q1 | 83.9% |
| 2022 | 4.9 | Q1 | 82.5% | 0.929 | Q1 | 84.5% |
| 2021 | 5.4 | Q1 | 81.2% | 0.936 | Q1 | 85.2% |
| 2020 | — | — | 1.130 | Q1 | 87.8% | |
| 2019 | — | — | 1.213 | Q1 | 89.4% | |
| 2018 | — | — | 1.402 | Q1 | 90.8% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1543-8392
ISSN
1543-8384
country
UScoverage
2004-2026